When human NHL cell lines became resistant to CD19 CAR T cells, adding HDAC inhibitors, vorinostat (a.k.a. SAHA) or panobinostat, largely reversed their resistance to CD19 CAR T cells (Torres-Collad and Jazirehi, 2018). The gene discussed is CD19; the disease is non-Hodgkin lymphoma.